TD Cowen Cuts Tilray Brands (NASDAQ:TLRY) Price Target to $7.00

Tilray Brands (NASDAQ:TLRY) had its price objective trimmed by TD Cowen from $10.00 to $7.00 in a research report released on Monday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Other analysts have also recently issued reports about the company. ATB Cormark Capital Markets upgraded Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Wednesday, December 10th. Canaccord Genuity Group started coverage on Tilray Brands in a research report on Tuesday, January 27th. They set a “hold” rating on the stock. Zacks Research raised shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research note on Wednesday, February 11th. Weiss Ratings reissued a “sell (d-)” rating on shares of Tilray Brands in a report on Wednesday, January 21st. Finally, Roth Mkm reduced their price objective on shares of Tilray Brands from $20.00 to $10.00 and set a “neutral” rating for the company in a research report on Tuesday, January 20th. Two investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $11.75.

Tilray Brands Trading Down 5.1%

TLRY stock opened at $6.14 on Monday. Tilray Brands has a 52-week low of $3.51 and a 52-week high of $23.20. The company has a quick ratio of 1.72, a current ratio of 2.81 and a debt-to-equity ratio of 0.19. The firm has a market cap of $715.35 million, a P/E ratio of -0.28 and a beta of 1.96. The company’s 50-day simple moving average is $7.37 and its 200-day simple moving average is $10.25.

Tilray Brands (NASDAQ:TLRY) last announced its quarterly earnings results on Thursday, January 8th. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.14) by $0.12. The firm had revenue of $217.51 million during the quarter, compared to analyst estimates of $211.15 million. Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.During the same quarter in the previous year, the business earned ($0.03) EPS. As a group, equities analysts forecast that Tilray Brands will post -0.2 EPS for the current fiscal year.

Institutional Trading of Tilray Brands

Several large investors have recently made changes to their positions in TLRY. Silverlake Wealth Management LLC purchased a new position in Tilray Brands in the 3rd quarter valued at $25,000. Oppenheimer & Co. Inc. purchased a new stake in shares of Tilray Brands during the third quarter worth $25,000. Unified Investment Management acquired a new stake in shares of Tilray Brands in the third quarter valued at about $26,000. J.W. Cole Advisors Inc. raised its position in shares of Tilray Brands by 203.2% in the second quarter. J.W. Cole Advisors Inc. now owns 71,890 shares of the company’s stock valued at $30,000 after buying an additional 48,177 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new position in shares of Tilray Brands in the third quarter worth about $30,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Record Q3 revenue and improving gross profit driven by international cannabis growth (organic revenue +11%, international cannabis up sharply). This is the core fundamental upside investors can point to. Tilray Q3 press release
• Positive Sentiment: Tilray reaffirmed FY26 guidance after the quarter, signaling management confidence that top‑line momentum and cost improvements will persist. Reaffirms outlook
• Positive Sentiment: Strategic beverage moves (BrewDog acquisition and new RTD partnerships/products such as Popsicle-branded RTDs and Shock Top product launches) expand beverage and U.S. RTD distribution — a multi‑year growth avenue. Business & M&A highlights
• Neutral Sentiment: Earnings call and transcripts add color: management outlined strategic priorities and cost actions, but acknowledged ongoing margin pressure in beverages and certain international markets — details that explain the mixed investor take. Earnings call transcript
• Negative Sentiment: Analyst downgrades and trimmed expectations (TD Cowen and others) after the print triggered concern about sustainable margins and beverage unit profitability; downgrades amplified the sell‑off. Analyst downgrade coverage
• Negative Sentiment: Market reaction: shares fell on the report despite the revenue beat — commentary and analyses point to margin and segment‑level concerns (beverages, some international markets) as the reasons investors aren’t celebrating the top‑line beat. Market reaction
• Negative Sentiment: Conflicting/uneven earnings metrics across outlets (some headlines show a narrowed loss or EPS beat while others report a bigger-than-expected loss) add short‑term confusion and volatility for traders. Earnings detail variation

Tilray Brands Company Profile

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.